Study: Antibody drug benefits patients with severe asthma

03/5/2009 | BBC

U.K. and Canadian researchers found that mepolizumab, an antibody treatment, effectively reduced asthma attacks and dependence on steroids in patients with severe asthma worsened by eosinophilia, a type of persistent airway inflammation. The antibody drug works by inhibiting the production of eosinophils, white blood cells that can cause eosinophilia when in high levels, one of the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC